On Monday, Oncology Institute Inc (NASDAQ: TOI) was -4.18%% drop from the session before settling in for the closing price of $2.39. A 52-week range for TOI has been $0.13 – $3.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -488.57%. When this article was written, the company’s average yearly earnings per share was at 46.48%. With a float of $40.96 million, this company’s outstanding shares have now reached $88.93 million.
Let’s determine the extent of company efficiency that accounts for 825 employees. In terms of profitability, gross margin is 10.42%, operating margin of -12.91%, and the pretax margin is -15.96%.
Oncology Institute Inc (TOI) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Oncology Institute Inc stocks. The insider ownership of Oncology Institute Inc is 55.44%, while institutional ownership is 14.73%. The most recent insider transaction that took place on Jun 05 ’25, was worth 2,054,712. In this transaction Director of this company sold 673,676 shares at a rate of $3.05, taking the stock ownership to the 13,950,557 shares. Before that another transaction happened on Jun 05 ’25, when Company’s Director sold 76,324 for $3.05, making the entire transaction worth $232,788. This insider now owns 1,272,724 shares in total.
Oncology Institute Inc (TOI) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 46.48% per share during the next fiscal year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
You can see what Oncology Institute Inc (TOI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Oncology Institute Inc (TOI)
Looking closely at Oncology Institute Inc (NASDAQ: TOI), its last 5-days average volume was 1.65 million, which is a jump from its year-to-date volume of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 20.11%.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 58.25%, which indicates a significant increase from 12.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.92% in the past 14 days, which was lower than the 132.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.68, while its 200-day Moving Average is $1.06. However, in the short run, Oncology Institute Inc’s stock first resistance to watch stands at $2.44. Second resistance stands at $2.58. The third major resistance level sits at $2.73. If the price goes on to break the first support level at $2.15, it is likely to go to the next support level at $2.00. Should the price break the second support level, the third support level stands at $1.86.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
There are 89,234K outstanding shares of the company, which has a market capitalization of 210.48 million. As of now, sales total 393,410 K while income totals -64,660 K. Its latest quarter income was 104,410 K while its last quarter net income were -19,590 K.
